These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6318626)
41. Anabolic androgenic steroids and a stroke in an athlete: case report. Frankle MA; Eichberg R; Zachariah SB Arch Phys Med Rehabil; 1988 Aug; 69(8):632-3. PubMed ID: 3408335 [TBL] [Abstract][Full Text] [Related]
42. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders. Santos AM; da Rocha MS; da Silva MF Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402 [TBL] [Abstract][Full Text] [Related]
44. The athletic polydrug abuse phenomenon. A case report. Hill JA; Suker JR; Sachs K; Brigham C Am J Sports Med; 1983; 11(4):269-71. PubMed ID: 6614301 [TBL] [Abstract][Full Text] [Related]
45. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280 [TBL] [Abstract][Full Text] [Related]
46. [Rhabdomyolysis in a bodybuilder using anabolic steroids]. Hageloch W; Appell HJ; Weicker H Sportverletz Sportschaden; 1988 Sep; 2(3):122-5. PubMed ID: 3242160 [TBL] [Abstract][Full Text] [Related]
47. Physiological performance, serum hormones, enzymes and lipids of an elite power athlete during training with and without androgens and during prolonged detraining. A case study. Häkkinen K; Alen M J Sports Med Phys Fitness; 1986 Mar; 26(1):92-100. PubMed ID: 3713166 [No Abstract] [Full Text] [Related]
48. Risk factors associated with the use of sex hormones. Taylor W Anticancer Res; 1987; 7(5B):943-8. PubMed ID: 2829703 [TBL] [Abstract][Full Text] [Related]
49. Sports medicine update. Loncarek K Scand J Med Sci Sports; 2002 Oct; 12(5):323. PubMed ID: 12383079 [No Abstract] [Full Text] [Related]
50. Power trip. Linehan T Nurs Times; 1993 Aug 11-17; 89(32):16-7. PubMed ID: 8233879 [No Abstract] [Full Text] [Related]
51. Frequency of use, awareness, and attitudes toward side effects of anabolic-androgenic steroids consumption among male medical students in Iran. Fayyazi Bordbar MR; Abdollahian E; Samadi R; Dolatabadi H Subst Use Misuse; 2014 Nov; 49(13):1751-8. PubMed ID: 25026387 [TBL] [Abstract][Full Text] [Related]
53. [Clinical, epidemiological, morphological and etiopathogenetic aspects of benign tumors of hepatocytic derivation, with description of a case of focal nodular hyperplasia]. Bontempini L; Wittels M; Franceschini F Arch De Vecchi Anat Patol; 1981 Dec; 64(3):547-68. PubMed ID: 6284066 [TBL] [Abstract][Full Text] [Related]
54. If youngsters overdose with anabolic steroids, what's the cost anatomically and otherwise? Cowart VS JAMA; 1989 Apr; 261(13):1856-7. PubMed ID: 2926916 [No Abstract] [Full Text] [Related]
55. [Letter: No increase of liver carcinoma following anabolic therapy]. Müting D Med Klin; 1973 Oct; 68(41):1343. PubMed ID: 4203093 [No Abstract] [Full Text] [Related]
56. Increased left ventricular mass in a bodybuilder using anabolic steroids. McKillop G; Todd IC; Ballantyne D Br J Sports Med; 1986 Dec; 20(4):151-2. PubMed ID: 2949795 [TBL] [Abstract][Full Text] [Related]
57. Gynaecomastia in bodybuilders. Neild D Br J Clin Pract; 1995; 49(4):172. PubMed ID: 7547153 [No Abstract] [Full Text] [Related]